undamentalytics Newsletter

Sandell Scott D and related entities: insider trades

Director, 10% owner at 13 companies we cover. 5 open-market purchases and 27 sales not made under a pre-set plan, reported from April 11, 2013 to March 12, 2026. Trades reported separately by several related funds or companies are counted once, under this name.

Would copying Sandell Scott D and related entities’s purchases have beaten the S&P 500?

Too few purchases to judge. Only 1 purchase has 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on April 24, 2024 into $3,552 by November 2, 2026, −33.8% a year. The copy held shares only 65% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $13,068, +11.2% a year (the S&P 500 held throughout made $15,410, +18.8% a year). Beta against the index was 1.24. Twelve months after each report, the average purchase was −82.6% against the S&P 500 (median −82.6%), and 0% beat it. Measured from the trade date, the insider’s own timing, the average was −85.3%. After their sales, the shares moved +75.4% against the index over 12 months on average (a negative figure means selling was the right call); 35% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$5.0k$10.0k$15.0k 202420252026 $15.4k$13.1k$3.6k
Copying Sandell Scott D and related entitiesS&P 500, same days investedS&P 500, held throughout $10,000 copying Sandell Scott D and related entities’s open-market purchases from April 24, 2024, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
−33.8%
S&P 500, same days invested
+11.2% (held throughout +18.8%)
Time in shares
65%
Sharpe ratio (S&P 500)
−0.08 (0.89)
Biggest drop (S&P 500)
−85% (−19%)
Market sensitivity (beta)
1.24
Purchases copied
2

Trade by trade

Sandell Scott D and related entities: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 2 −22.7% −22.7% 0% 2 — — Not enough years
Purchases, 6 months after the report 2 −7.3% −7.3% 0% 2 — — Not enough years
Purchases, 12 months after the report 1 −82.6% −82.6% 0% 1 — — Not enough years
Purchases, 12 months after the trade 1 −85.3% −85.3% 0% 1 — — Not enough years
Sales, 3 months after the report 20 +14.8% +6.6% 30% 6 0.32 0.76 No reliable evidence
Sales, 12 months after the report 20 +75.4% +54.9% 35% 6 0.64 0.55 No reliable evidence
Sales, 12 months after the trade 20 +80.4% +59.7% 35% 7 1.04 0.34 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Cloudflare, Inc. NET —09May 21, 2020August 9, 2023
Senseonics Holdings, Inc. SENS —13March 23, 2016April 23, 2020
Robinhood Markets HOOD —03February 1, 2022May 16, 2022
Crescent Biopharma, Inc. CBIO —03January 4, 2023January 27, 2023
Workday, Inc. WDAY —02April 11, 2013March 4, 2014
Supernus Pharmaceuticals, Inc. SUPN —02June 17, 2015June 19, 2015
Ardelyx, Inc. ARDX —02June 12, 2020December 27, 2021
Korro Bio, Inc. KRRO —20April 23, 2024March 12, 2026
Groupon, Inc. GRPN —01August 16, 2013August 16, 2013
Sprout Social, Inc. SPT —01August 18, 2020August 18, 2020
Enliven Therapeutics, Inc. ELVN —01January 3, 2022January 3, 2022
Trevi Therapeutics, Inc. TRVI —10April 13, 2022April 13, 2022
Savara Inc SVRA —10July 19, 2023July 19, 2023

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
March 12, 2026March 10, 2026 KRRO Purchase $2,300,881 −21.6%not yetnot yet
April 23, 2024April 22, 2024 KRRO Purchase $999,992 −23.9%−82.6%−85.3%
August 9, 2023August 8, 2023 NET Sale $1,325,212 +3.6%−0.2%−4.5%
July 19, 2023July 17, 2023 SVRA Purchase $999,999 not yetnot yetnot yet
January 27, 2023January 25, 2023 CBIO Sale $11,485,572 not yetnot yetnot yet
January 6, 2023January 5, 2023 CBIO Sale $196,959 not yetnot yetnot yet
January 4, 2023December 30, 2022 CBIO Sale $1,185,899 not yetnot yetnot yet
May 16, 2022May 12, 2022 HOOD Sale $73,941 −1.4%−18.7%−6.0%
May 4, 2022May 3, 2022 HOOD Sale $19,637 −2.3%−17.5%−15.0%
April 13, 2022April 11, 2022 TRVI Purchase $6,802,999 not yetnot yetnot yet
February 1, 2022January 31, 2022 HOOD Sale $29,606 −16.4%−15.0%−16.6%
January 3, 2022December 30, 2021 ELVN Sale $266,965 −41.6%+100.9%+98.6%
December 27, 2021December 9, 2021 ARDX Sale $3,632,772 not yetnot yetnot yet
November 20, 2020November 19, 2020 NET Sale $22,314,136 +1.1%+146.6%+187.4%
November 18, 2020November 16, 2020 NET Sale $29,442,333 +8.5%+187.4%+197.5%
November 13, 2020November 12, 2020 NET Sale $5,491,952 +20.1%+197.5%+185.0%
August 21, 2020August 19, 2020 NET Sale $17,576,401 +70.7%+193.0%+168.3%
August 18, 2020August 17, 2020 SPT Sale $94,650,765 +32.3%+181.1%+196.1%
August 18, 2020August 14, 2020 NET Sale $9,896,510 +60.5%+168.3%+178.0%
August 13, 2020August 11, 2020 NET Sale $23,620,356 +61.3%+178.0%+179.4%
August 10, 2020August 10, 2020 NET Sale $3,445,222 +63.8%+179.4%+205.3%
June 12, 2020June 11, 2020 ARDX Sale $573,192 −15.9%−29.7%−24.7%
May 21, 2020May 20, 2020 NET Sale $9,637,037 +22.3%+135.0%+128.3%
April 23, 2020April 21, 2020 SENS Sale $105,349 not yetnot yetnot yet
April 20, 2020April 16, 2020 SENS Sale $138,886 not yetnot yetnot yet
April 15, 2020April 13, 2020 SENS Sale $119,852 not yetnot yetnot yet
March 23, 2016March 23, 2016 SENS Purchase $4,499,999 not yetnot yetnot yet
June 19, 2015June 17, 2015 SUPN Sale $2,254,252 +22.9%+8.9%+14.6%
June 17, 2015June 16, 2015 SUPN Sale $1,614,567 +29.4%+4.6%+9.0%
March 4, 2014February 28, 2014 WDAY Sale $535,470 −31.6%−35.6%−35.2%
August 16, 2013August 15, 2013 GRPN Sale $345,369 +2.9%−57.2%−58.6%
April 11, 2013April 10, 2013 WDAY Sale $605,775 +4.7%+0.6%+20.8%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Sandell Scott D and related entities traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.